MedKoo Cat#: 529157 | Name: Enkephalin, pen(2,5)-

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Enkephalin, pen(2,5)- is a bioactive chemical.

Chemical Structure

Enkephalin, pen(2,5)-
Enkephalin, pen(2,5)-
CAS#88381-29-7

Theoretical Analysis

MedKoo Cat#: 529157

Name: Enkephalin, pen(2,5)-

CAS#: 88381-29-7

Chemical Formula: C30H41N5O7S2

Exact Mass: 647.2447

Molecular Weight: 647.81

Elemental Analysis: C, 55.62; H, 6.38; N, 10.81; O, 17.29; S, 9.90

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Enkephalin, pen(2,5)-
IUPAC/Chemical Name
D-Valine, 3-mercapto-N-(N-(N-(3-mercapto-N-L-tyrosyl-D-valyl)glycyl)-L-phenylalanyl)-
InChi Key
MSKPPUMCXBULRR-WMIMKTLMSA-N
InChi Code
InChI=1S/C30H41N5O7S2/c1-29(2,43)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44/h5-13,20-21,23-24,36,43-44H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20-,21-,23-,24-/m0/s1
SMILES Code
CC(C)(S)[C@H](C(O)=O)NC([C@H](CC1=CC=CC=C1)NC(CNC([C@@H](C(C)(S)C)NC([C@H](CC2=CC=C(O)C=C2)N)=O)=O)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 647.81 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: He SF, Jin SY, Yang W, Pan YL, Huang J, Zhang SJ, Zhang L, Zhang Y. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure. Br J Anaesth. 2018 Jul;121(1):26-37. doi: 10.1016/j.bja.2017.11.110. Epub 2018 Feb 2. PubMed PMID: 29935580. 2: Tseng TJ, Yang ML, Hsieh YL, Ko MH, Hsieh ST. Nerve Decompression Improves Spinal Synaptic Plasticity of Opioid Receptors for Pain Relief. Neurotox Res. 2018 Feb;33(2):362-376. doi: 10.1007/s12640-017-9799-5. Epub 2017 Aug 23. PubMed PMID: 28836121. 3: McDonnell C, Leánez S, Pol O. The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice. PLoS One. 2017 Jul 10;12(7):e0180998. doi: 10.1371/journal.pone.0180998. eCollection 2017. PubMed PMID: 28700700; PubMed Central PMCID: PMC5507309. 4: Margolis EB, Fujita W, Devi LA, Fields HL. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology. 2017 Sep 1;123:420-432. doi: 10.1016/j.neuropharm.2017.06.019. Epub 2017 Jun 21. PubMed PMID: 28645621; PubMed Central PMCID: PMC5563499. 5: Stefanucci A, Novellino E, Mirzaie S, Macedonio G, Pieretti S, Minosi P, Szűcs E, Erdei AI, Zádor F, Benyhe S, Mollica A. Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge. ACS Med Chem Lett. 2017 Mar 14;8(4):449-454. doi: 10.1021/acsmedchemlett.7b00044. eCollection 2017 Apr 13. PubMed PMID: 28435535; PubMed Central PMCID: PMC5392763. 6: Yokota E, Koyanagi Y, Yamamoto K, Oi Y, Koshikawa N, Kobayashi M. Opioid subtype- and cell-type-dependent regulation of inhibitory synaptic transmission in the rat insular cortex. Neuroscience. 2016 Dec 17;339:478-490. doi: 10.1016/j.neuroscience.2016.10.004. Epub 2016 Oct 8. PubMed PMID: 27725218. 7: Sullivan LC, Chavera TS, Jamshidi RJ, Berg KA, Clarke WP. Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons. J Pharmacol Exp Ther. 2016 Dec;359(3):411-419. Epub 2016 Sep 22. PubMed PMID: 27660244; PubMed Central PMCID: PMC5118646. 8: Castany S, Carcolé M, Leánez S, Pol O. The antinociceptive effects of a δ-opioid receptor agonist in mice with painful diabetic neuropathy: Involvement of heme oxygenase 1. Neurosci Lett. 2016 Feb 12;614:49-54. doi: 10.1016/j.neulet.2015.12.059. Epub 2016 Jan 4. PubMed PMID: 26762785. 9: Blaesse P, Goedecke L, Bazelot M, Capogna M, Pape HC, Jüngling K. μ-Opioid Receptor-Mediated Inhibition of Intercalated Neurons and Effect on Synaptic Transmission to the Central Amygdala. J Neurosci. 2015 May 13;35(19):7317-25. doi: 10.1523/JNEUROSCI.0204-15.2015. PubMed PMID: 25972162; PubMed Central PMCID: PMC4429148. 10: Bird MF, Vardanyan RS, Hruby VJ, Calò G, Guerrini R, Salvadori S, Trapella C, McDonald J, Rowbotham DJ, Lambert DG. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands. Br J Anaesth. 2015 Apr;114(4):646-56. doi: 10.1093/bja/aeu454. Epub 2015 Feb 13. PubMed PMID: 25680364. 11: Carcolé M, Castany S, Leánez S, Pol O. Treatment with a heme oxygenase 1 inducer enhances the antinociceptive effects of µ-opioid, δ-opioid, and cannabinoid 2 receptors during inflammatory pain. J Pharmacol Exp Ther. 2014 Oct;351(1):224-32. doi: 10.1124/jpet.114.215681. PubMed PMID: 25204546. 12: Salman S, Holloway AC, Nurse CA. Chronic opioids regulate KATP channel subunit Kir6.2 and carbonic anhydrase I and II expression in rat adrenal chromaffin cells via HIF-2α and protein kinase A. Am J Physiol Cell Physiol. 2014 Aug 1;307(3):C266-77. doi: 10.1152/ajpcell.00135.2014. Epub 2014 Jun 4. PubMed PMID: 24898587; PubMed Central PMCID: PMC4121586. 13: Jin J, Xu GX, Yuan ZL. Influence of the hypothalamic arcuate nucleus on intraocular pressure and the role of opioid peptides. PLoS One. 2014 Apr 1;9(4):e82315. doi: 10.1371/journal.pone.0082315. eCollection 2014. PubMed PMID: 24691128; PubMed Central PMCID: PMC3972173. 14: Velázquez-Marrero C, Ortiz-Miranda S, Marrero HG, Custer EE, Treistman SN, Lemos JR. μ-Opioid inhibition of Ca2+ currents and secretion in isolated terminals of the neurohypophysis occurs via ryanodine-sensitive Ca2+ stores. J Neurosci. 2014 Mar 5;34(10):3733-42. doi: 10.1523/JNEUROSCI.2505-13.2014. PubMed PMID: 24599471; PubMed Central PMCID: PMC3942588. 15: Kaneko K, Mizushige T, Miyazaki Y, Lazarus M, Urade Y, Yoshikawa M, Kanamoto R, Ohinata K. δ-Opioid receptor activation stimulates normal diet intake but conversely suppresses high-fat diet intake in mice. Am J Physiol Regul Integr Comp Physiol. 2014 Feb 15;306(4):R265-72. doi: 10.1152/ajpregu.00405.2013. Epub 2014 Jan 8. PubMed PMID: 24401991. 16: Tudashki HB, Robertson DN, Schiller PW, Pineyro G. Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses. Mol Pharmacol. 2014 Jan;85(1):148-61. doi: 10.1124/mol.113.089003. Epub 2013 Oct 30. PubMed PMID: 24174495; PubMed Central PMCID: PMC3868905. 17: Bodnar RJ. Endogenous opiates and behavior: 2012. Peptides. 2013 Dec;50:55-95. doi: 10.1016/j.peptides.2013.10.001. Epub 2013 Oct 12. Review. PubMed PMID: 24126281. 18: Guo C, He L, Yao D, A J, Cao B, Ren J, Wang G, Pan G. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes. Toxicol Lett. 2014 Jan 3;224(1):93-100. doi: 10.1016/j.toxlet.2013.09.019. Epub 2013 Oct 9. PubMed PMID: 24120425. 19: Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, Shaw DB, Sahr AE, Adams BL, Quimby SJ, Diaz N, Jimenez A, Pedregal C, Mitch CH, Knopp KL, Anderson WH, Cramer JW, McKinzie DL. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders. Neuropharmacology. 2014 Feb;77:131-44. doi: 10.1016/j.neuropharm.2013.09.021. Epub 2013 Sep 23. PubMed PMID: 24071566. 20: Mitchell JM, Margolis EB, Coker AR, Allen DC, Fields HL. Intra-VTA deltorphin, but not DPDPE, induces place preference in ethanol-drinking rats: distinct DOR-1 and DOR-2 mechanisms control ethanol consumption and reward. Alcohol Clin Exp Res. 2014 Jan;38(1):195-203. doi: 10.1111/acer.12246. Epub 2013 Aug 27. PubMed PMID: 24033469.